Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria

Annals of Tropical Medicine and Parasitology
E C EmukahMoses Katabarwa

Abstract

In areas of Nigeria where onchocerciasis is endemic, community-directed distributors (CDD) distribute ivermectin annually, as part of the effort to control the disease. Unfortunately, it has been reported that at least 35% of the distributors who have been trained in Nigeria are unwilling to participate further as CDD. The selection and training of new CDD, to replace those unwilling to continue, leads to annual expense that the national onchocerciasis-programme is finding difficult to meet, given other programme priorities and the limited resources. If the reported levels of attrition are true, they seriously threaten the sustainability of community-directed treatment with ivermectin (CDTI) in Nigeria. In 2002, interviews were held with 101 people who had been trained as CDD, including those who had stopped serving their communities, from 12 communities in south-eastern Nigeria that had high rates of CDD attrition. The results showed that, although the overall reported CDD attrition was 40.6%, the actual rate was only 10.9%. The CDD who had ceased participating in the annual rounds of ivermectin blamed a lack of incentives (65.9%), the demands of other employment (14.6%), the long distances involved in the house-to-house distr...Continue Reading

References

Oct 1, 1994·Annals of Tropical Medicine and Parasitology·P NgoumouJ M Mace
May 18, 2001·Best Practice & Research. Clinical Haematology·K MrózekC D Bloomfield
Mar 4, 2005·Retrovirology·Kiyoshi Takatsuki

❮ Previous
Next ❯

Citations

Jun 8, 2013·Trends in Parasitology·Goylette F ChamiDavid W Dunne
Jan 29, 2010·Transactions of the Royal Society of Tropical Medicine and Hygiene·Moses N KatabarwaDeborah McFarland
Mar 20, 2013·BMC Health Services Research·Rènée du ToitPaul Courtright
May 18, 2013·American Journal of Public Health·Sarah Wood PallasElizabeth H Bradley
Sep 14, 1999·Australian and New Zealand Journal of Ophthalmology·R DandonaG N Rao
Oct 9, 2009·The New England Journal of Medicine·Yaya I CoulibalyAmy D Klion
Apr 10, 2014·Human Resources for Health·James S MillerGerald A Paccione
May 17, 2014·Journal of Biosocial Science·H HalwindiA Olsen
Mar 29, 2018·Infectious Diseases of Poverty·Robert ColebundersAdrian Hopkins
Dec 15, 2015·PLoS Neglected Tropical Diseases·Gregory S GreeneShannath L Merbs
Jul 26, 2017·Proceedings of the National Academy of Sciences of the United States of America·Goylette F ChamiEdridah M Tukahebwa
Jan 8, 2015·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Kate J YorkElena Schmidt
Sep 15, 2016·American Journal of Community Psychology·Lauren M Hodge, Karen M T Turner
Jul 5, 2017·Human Resources for Health·Jan-Walter De NeveThomas J Bossert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.